Results 21 to 30 of about 27,286 (175)

A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer Therapy. [PDF]

open access: yesPLoS ONE, 2015
AS1411 (previously known as AGRO100) is a 26 nucleotide guanine-rich DNA aptamer which forms a guanine quadruplex structure. AS1411 has shown promising utility as a treatment for cancers in Phase I and Phase II clinical trials without causing major side ...
Thu Le Trinh   +7 more
doaj   +2 more sources

Multifunctional molecular hybrid for targeted colorectal cancer cells: Integrating doxorubicin, AS1411 aptamer, and T9/U4 ASO. [PDF]

open access: yesPLoS One
Colorectal cancer (CRC) poses a global health challenge, with current treatments often harming both cancerous and normal cells. To improve efficacy, a multifunctional drug delivery platform has been developed, integrating bioactive materials, anticancer ...
Jiramitmongkon K   +4 more
europepmc   +3 more sources

AS1411-functionalized albumin nanoparticles for nucleolin-targeted realgar delivery and therapy in triple-negative breast cancer. [PDF]

open access: yesFront Pharmacol
Realgar (As4S4) has shown antitumor activity, but its pharmaceutical application is limited by poor aqueous solubility, low bioavailability, and systemic toxicity. In this study, we developed AS1411-functionalized albumin nanoparticles (As4S4@ BSA-AS1411
Dong L, Ran W, Li Y, Yang L, Zhou X.
europepmc   +3 more sources

Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers

open access: yesInternational Journal of Biological Macromolecules, 2018
AS1411 is a nucleolin-binding aptamer which attracted great interest as active targeting ligand for the selective delivery of therapeutic agents to tumour cells.
Musumeci Domenica   +13 more
core   +6 more sources

Phosphorothioated amino-AS1411 aptamer functionalized stealth nanoliposome accelerates bio-therapeutic threshold of apigenin in neoplastic rat liver: a mechanistic approach. [PDF]

open access: yesJ Nanobiotechnology, 2023
Hepatocellular carcinoma (HCC) is a leading cause of death globally. Even though the progressive invention of some very potent therapeutics has been seen, the success is limited due to the chemotherapeutic resistance and recurrence in HCC.
Dhara M   +6 more
europepmc   +2 more sources

Exploring the G-Quadruplex Formation of AS1411 Derivatives

open access: yesMolecules
AS1411 is a G-quadruplex (G4) aptamer that binds tightly to nucleolin (NCL) on the cell surface and has shown strong anticancer effects. However, this aptamer is highly polymorphic, presenting different types of G4s, which may hinder its preclinical ...
Pedro Lourenço   +9 more
doaj   +2 more sources

Anti-Proliferative Effect of Doxorubicin-Loaded AS1411 Aptamer on Colorectal Cancer Cell. [PDF]

open access: yesAsian Pac J Cancer Prev, 2021
Doxorubicin (Dox) inhibits DNA replication and causes DNA damage resulting in cell death. It is a common drug for treatment of many cancers. Treatment efficacy and side effects of Dox are critical issues in using it because the drug lacks of specificity. The objective of this study was to improve the specificity of Dox by the incorporation of this drug
Lohlamoh W   +2 more
europepmc   +4 more sources

Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment. [PDF]

open access: yesInt J Nanomedicine, 2021
Xiao Liang,* Yudi Wang,* Hui Shi, Mengmeng Dong, Haobo Han, Quanshun Li Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun, 130012, People’s Republic of China*These
Liang X   +5 more
europepmc   +2 more sources

A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression

open access: yesMolecular Therapy: Nucleic Acids, 2022
Immune-checkpoint blockade (ICB) therapy has changed the clinical outcome of many types of aggressive tumors, but there still remain many cancer patients that do not respond to these treatments.
Daniel Meraviglia-Crivelli   +6 more
doaj   +1 more source

Aptamer-modified carbon dots for enhancement of photodynamic therapy of cancer cells

open access: yesTalanta Open, 2022
Carbon dots (CDs) have emerged as promising materials for photodynamic therapy (PDT) because of their intriguing photochemical properties, high stability, and low toxicity.
Menghui Ma   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy